secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2026-07-16T20:05:43+00:00
Accession:  0001493152-26-033514
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech shareholders approve reverse stock split and warrant/note conversion issuances
--------------------------------------------------------------------------------

- Special meeting held July 15, 2026; quorum of 10,671,690 shares (38.5%) present.
- Proposals 1-5 approved: issuance of >19.99% of shares upon exercise of Class H, I, J warrants and conversion of two promissory notes.
- Proposal 6 approved: reverse stock split at ratio up to 1-for-25, ratio at Board discretion.
- Proposal 7 approved: adjournment if needed to solicit additional proxies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315226033514/0001493152-26-033514-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315226033514/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-033514

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer